OCTRI: Novel Research Methodology Development Q&A session, Nov. 19

OCTRI’s Novel Research Methodology Development Award provides funding over a one-year period to encourage and accelerate the creation, dissemination, and implementation of novel translational and clinical research methodologies.

Two levels of novel research methodology funding are available:

1. Development and dissemination of novel research methodologies (up to $25,000)

2. Publication/dissemination of novel research methodologies (up to $5,000)

For examples of pilot projects that would be viewed as responsive please see the full request for applications on the OCTRI website: OCTRI Funding Opportunities.

Novel Research Methodology Development Award: Informational Q&A session
Wednesday, Nov. 19, 2014
12 to 1 p.m.
BICC 124

Those on hand to answer questions include:

  • Eric Orwoll, OCTRI Director
  • David Ellison, OCTRI Associate Director
  • Colleen Lay, OCTRI Awards Program Director
  • Jonathan Jubera, OCTRI Awards Project Manager

Questions? Please contact Jonathan Jubera.

American Asthma Foundation seeking investigators outside the field of asthma

The American Asthma Foundation is looking to draw outstanding early- and mid-career scientists from other fields into the study of asthma. The Scholars Program is designed to achieve this goal by supporting highly innovative research from all fields relevant to asthma. Most scholars will be studying asthma for the first time.

Award: Up to $150,000 per year for up to three years.
Deadline: February 4, 2015
Eligibility: Applicants should have an independent research program with national-level, independent funding. The applicant will have been appointed to an independent faculty position no more than 10 years before the application deadline.

For other funding opportunities, take a look at this week’s Funding Alerts.

Research courtyard: Construction project starting soon

The third phase of the North Campus Utility Plant project behind Richard Jones Hall is expected to begin Saturday, Nov. 8, and continue in stages into the new year. The work includes positioning a crane in the research courtyard, lifting materials and equipment over the top of RJH, and installing supports and cooling towers on the backside of RJH and the Vollum Institute.

If you work in the affected areas or have visitors, impacts may include:

  • The courtyard and courtyard entrances to RJH, the Vollum, and Mackenzie Hall will have limited access. The primary entrances to these buildings will be through the Oregon Institute of Occupational Health Sciences (formerly CROET) or Medical Research Building (MRB). Fencing and signage will be installed in the appropriate locations.
  • ID badges will need to be programmed to allow after-hours access through CROET, RJH, the Vollum, Mac Hall, and the MRB.
  • During crane work, faculty, staff and students on the top two floors of RJH will be periodically and briefly evacuated similar to previous years.
  • There will be increased noise and vibrations throughout construction
  • Periodic coordinated power outages in research buildings may also occur as part of the NCUP project and a transformer upgrade. More information will be provided when this phase of work gets closer.

Project schedule
Following is a scheduled timeline for the project:

Saturday, Nov. 8 through Wednesday, Nov. 12

  • About half the Auditorium parking lot will be closed for delivery of the crane.
  • Temporary protective plating will be placed in the research courtyard.
  • Barrier fencing will be installed along the perimeter of the courtyard.

Saturday, Nov. 15 through early January

  • Crane assembly in courtyard
  • Weatherization on exterior of Vollum to occur (parallel project)
  • Crane/construction work hours are 6:30 a.m. to 3:30 p.m., Monday through Friday
  • The top two floors of RJH will be evacuated intermittently for safety, as in previous years.
  • Pedestrian access through RJH, Vollum, MRB and Mac Hall only; limited courtyard access
  • As in previous years, the underground tunnel will be reshored with four-foot travel path for animal transport for the duration of the project.

Community forum
A forum is being held for faculty and other members of the OHSU community to learn more about the project and ask questions.

Thursday, Oct. 30
1 to 3 p.m.
Old Library Auditorium

Project managers will be on hand to discuss plans, impacts and proposed schedules. Attendees may ask questions and sign up for one-on-one meetings with project managers to talk through individual needs and concerns.

Questions or concerns?
Contact Jerry Witt of Facilities & Logistics: 503 494-5905

Letters of Intent for OCTRI biomedical innovation program due Nov. 12

The Oregon Clinical & Translational Research Institute (OCTRI) is now accepting letters of intent to apply for its Biomedical Innovation Program. The program cultivates and selects promising translational projects that develop new biomedical devices, diagnostics, and software with the objective of moving innovative technologies to clinical application, making a meaningful impact on human health.

Deadline: Letters of intent due Nov. 12, 2014
Amount: Up to $40,000 over one year
Eligibility: Principal investigators must fit OHSU eligibility requirements.

Critical elements of successful proposals will be a well-developed idea or vision for the end product and a collaboration between clinicians, scientists, and bioengineers. That collaboration will make possible the identification of a significant clinical problem, an innovative idea for a device or diagnostic to address the problem, bioengineering approaches for device or diagnostic development, voice of consumer studies, and early clinical trials.

Learn more about this and other OCTRI funding opportunities.

Symposium on Genome Instability, Oct. 24

In response to a growing interest in research strategies for the early detection of cancers, Dr. Joe Gray of the Center for Spatial Systems Biomedicine, Dr. R. Stephen Lloyd of the Oregon Institute of Occupational Health Sciences and Dr. Brian Druker of the Knight Cancer Institute are hosting a symposium titled Genomic Instability and Cancer: Early Detection and Novel Therapeutics. The main topic will be early detection of cancer using genomic instability as a marker.

Speakers include Alan Ashworth of UCSF, Arthur Grollman of SUNY Stony Brook, Rick Wood of M.D. Anderson Cancer Center, Rosana Risques of the University of Washington, and a number of OHSU faculty.

The symposium will run all day Friday, Oct. 24, beginning at 8:30 a.m. in the Old Library Auditorium. Food and beverage will be provided throughout the day, with a wine and appetizer reception after the final talk. Registration is free.

DoD Broad Agency Announcement for Extramural Medical Research

The U.S. Army Medical Research and Materiel Command has a new funding opportunity available: the Extramural Medical Research program. This program must be for basic and applied research and must be for scientific study and experimentation directed toward advancing the state-of-the-art or increasing knowledge and understanding rather than focusing on a specific system or hardware solution. Research and development funded through this program are intended and expected to benefit and inform both military and civilian medical practice and knowledge.

The research program areas are:

  • Military Infectious Diseases – Focuses on vaccines, anti-parasitic drugs, deployable field clinical diagnostics (human and vector), prophylactics and novel therapeutics to treat multidrug-resistant organisms in combat wound infections, as well as vector control pertinent to naturally occurring endemic diseases with demonstrated or potential capability to decrease military operational effectiveness.
  • Combat Casualty Care – Provides integrated capabilities for far-forward medical care to reduce the mortality and morbidity associated with major combat-related trauma across the spectrum of combat casualty care including point-of-injury and pre- or out-of-hospital care, the spectrum of en-route care, and facilities-based treatment.
  • Military Operational Medicine – Conducts biomedical research to deliver products and solutions to the Service member that address health and fitness throughout the deployment cycle. The program is centered on cutting-edge scientific research and bringing science to the Service member on the battlefield in a relevant, timely manner.
  • Clinical and Rehabilitative Medicine – Focuses on the innovations required to reset our wounded Service members, both in terms of duty performance and quality of life.
  • Medical Biological Defense – Provides medical countermeasures for biological warfare agents.
  • Medical Chemical Defense – Seeks to preserve combat effectiveness by timely provision of medical countermeasures in response to Joint Service chemical warfare defense requirements.
  • Medical Simulation and Information Sciences – The mission of this program is to explore the implications of models and technology for medical education and for the provision, management and support of health services in the military.
  • Radiation Health Effects – Focuses on developing medical countermeasures for acute ionizing radiation injury.
  • Special Investment Areas/Innovation Funding – Seeking new and innovative science that promises benefit to military health and medicine.

Awards are made to organizations only. Eligible investigators include all individuals, regardless of ethnicity, nationality, or citizenship status, who are employed by, or affiliated with, an eligible organization. A specific amount of funding has NOT been set aside for this Announcement, and the number of awards is indeterminate and contingent upon funding availability. The total period of performance may be up to five years, except for the “Special Investment Areas/Innovation Funding” area of interest. Those projects are generally 18 months or less in duration and limited to $500,000 total.

Pre-proposal deadline: September 30, 2015

Event: What Can Your Genes Tell You?

Please Join Us for the 2014 Portland Series Launch:

What Can Your Genes Tell You?

Value, validity and implications of direct to consumer genetic testing for personal health data. Co-facilitated by Summer Cox, MPH and Shaban Demirel, PhD.

October 21, 2014 5:45 – 7:30 p.m.

The Lucky Labrador Pub (all ages)
915 SE Hawthorne Blvd., Portland, OR 97214

$5 General Admission

Includes discussion and first glass of wine/beer if 21+

REGISTER at http://www.nwabr.org/communityconversation/portland

What are Community Conversations?

Each informal Conversation explores a topic in biomedical science and its relationship with ethics, medicine, research and society, connecting people to the biomedical research community. Learning from each other, our goal is to help people thoughtfully engage in and advance biomedical research. Everyone is welcome. No science background necessary.

In partnership with NWABR members Oregon Health & Science University and Portland State University and supporters Legacy Research Institute and Oregon Health Authority

NIH Common Fund Video Competition winners announced

Go with the CTSC and the NIH Common Fund: A RapDid you know that the NIH Common Fund was holding a video competition to commemorate its 10-year anniversary? Neither did we, but after seeing this Common Fund rap, we will definitely be going with the Common Fund.

TTBD Lunch & Learn: Keeping a Lab Notebook, Oct. 21

A laboratory notebook is critical to document research that may form the basis of a patentable invention. An accurate record can show who made the invention, the contributions of each inventor, and how the invention was made. Senior Technology Development Manager Michele Gunness will lead this seminar to present updates on patent law and best practices to maintain your laboratory notebook to assist your attorney when preparing a patent application and providing support to your invention. 

This event is open to all OHSU employees, faculty and students. Admission is free and no RSVP is necessary. The event will be catered by Ingallina’s Box Lunch. Lunches will be provided on a first-come, first-served basis.

Tuesday, October 21, 2014
Marquam Hill Campus, Mackenzie Hall 2201 

For questions or concerns, please contact Karen Ho.



Nomination deadline for Gruber Genetics and Neuroscience Prizes is Dec. 15

Genetics Prize

The unrestricted $500,000 prize is presented to a leading scientist, or group of scientists (up to three), in recognition of groundbreaking contributions to any realm of genetics research. These contributions may include original discoveries in genetic function, regulation, transmission, and variation, as well as in genomic organization. Nominations may be submitted by individuals, organizations, and institutions that are active in or have an appreciation for contemporary genetic research or problems.

Neuroscience Prize

This unrestricted cash award of $500,000 is awarded each year to a person or persons chosen by a distinguished advisory board of neuroscience experts from nominations that are received from around the world. Nominations for this prize are invited annually and may be submitted by individuals, organizations, and institutions that are active in or have an appreciation for contemporary neuroscience research and study. Individuals from anywhere in the world who have conducted highly distinguished research in the field of the brain, spinal cord, or peripheral nervous system may be nominated.

The nomination deadline for both the Neuroscience and Genetics Prizes is December 15, 2014.

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Read more

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.